DFT, molecular docking and molecular dynamics simulation studies on natural chromone derivatives from Cassia nomame for their possible antiviral activity against Coronavirus, SARS-CoV-2
Abstract
Keywords
COVID-19, Chromone derivatives, Cassia nomame, Molecular docking, Molecular dynamics simulation.
Supporting Institution
Thanks
References
- [1] Cheng C.Y., Lee Y.L., Chen C.P., Lin Y.C., Liu C.E., Liao C.H., Cheng S.H., Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan, Journal of Microbiology, Immunology and Infection, 53 (2020) 488–492.
- [2] Lin M.H., Moses D.C., Hsieh C.H., Cheng S.C., Chen Y.H., Sun C.Y., Chou C.Y., Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes, Antiviral Research, 150 (2018) 155–163.
- [3] Yu R., Chen L., Lan R., Shen R., Li P., Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking, International Journal of Antimicrobial Agents, 56(2) (2020) 106012.
- [4] Elfiky A.A., Ribavirin, Remdesivir, Sofosbuvir, Galidesivir and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study, Life Sciences, 253 (2020).
- [5] Cai Q., Yang M., Liu D., Chen J., Shu D., Xia J., Liao X., Gu Y., Cai Q., Yang Y., Shen C., Li X., Peng L., Huang D., Zhang J., Zhang S., Wang F., Liu J., Chen L., Chen S., Wang Z., Zhang Z., Cao R., Zhong W., Liu Y., Liu L., Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study, Engineering, 6 (2020) 1192–1198.
- [6] Choy K.T.,. Wong A.Y.L, Kaewpreedee P., Sia S.F., Chen D., Hui K.P.Y., Chu D.K.W., Chan M.C.W., Cheung P.P.H., Huang X., Peiris M., Yen H.L., Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro, Antiviral Research, 178 (2020) 104786.
- [7] McKee D.L., Sternberg A., Stange U., Laufer S., Naujokat C., Candidate drugs against SARS-CoV-2 and COVID-19, Pharmacological Research, 157 (2020) 104859.
- [8] Erdogan T., DFT, molecular docking and molecular dynamics simulation studies on some newly introduced natural products for their potential use against SARS-CoV-2, Journal of Molecular Structure, 1242 (2021) 130733.
- [9] Liu X., Wang X.J., Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines, Journal of Genetics and Genomics, 47 (2020) 119–121.
- [10] Xu Z., Peng C., Shi Y., Zhu Z., Mu K., Wang X., Zhu W., Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation, BioRxiv, (2020) 2020.01.27.921627.